advertisement

WGC-2021

11.4 Prostaglandins (69)

Showing records 1 to 25

Display all abstracts in classification 11.4 Prostaglandins

Search within classification 11.4 Prostaglandins
90379 Comparison of the effectiveness and safety of travoprost and latanoprost for the management of open-angle glaucoma given as an evening dose
Li J
Experimental and therapeutic medicine 2020; 20: 24
90461 High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina
Harper MM
Current Eye Research 2020; 0: 1-7
90215 The influence of topical non-steroidal anti-inflammatory drugs on the intraocular pressure lowering effect of topical prostaglandin analogues-A systemic review and meta-analysis
Lo KJ
PLoS ONE 2020; 15: e0239233
90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Guo Y
BMC Ophthalmology 2020; 20: 277
90697 Lower Eyelid Horizontal Tightening in Prostaglandin Associated Periorbitopathy
Procianoy F
Ophthalmic Plastic and Reconstructive Surgery 2020; 0:
90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Schnichels S
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260
90176 Efficacy of bimatoprost for the treatment of primary open-angle glaucoma: A protocol of systematic review and meta-analysis
Liu HW
Medicine 2020; 99: e20356
90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Aihara M
American Journal of Ophthalmology 2020; 220: 53-63
90626 Effects of Topical Prostaglandin Analog on Macular Thickness Following Cataract Surgery with Postoperative Topical Bromfenac Treatment
Park KS
Journal of clinical medicine 2020; 9:
90753 Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
Hu J
British Journal of Ophthalmology 2020; 104: 1040-1044
90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Ismail A
International Journal of Pharmaceutics 2020; 583: 119402
90215 The influence of topical non-steroidal anti-inflammatory drugs on the intraocular pressure lowering effect of topical prostaglandin analogues-A systemic review and meta-analysis
Lo KJ
PLoS ONE 2020; 15: e0239233
90779 Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma
Kim JS
Ophthalmology. Glaucoma 2020; 3: 288-294
90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Aihara M
Japanese Journal of Ophthalmology 2020; 64: 398-406
90618 Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment
Hurst J
Nanomedicine: Nanotechnology, Biology, and Medicine 2020; 29: 102260
90176 Efficacy of bimatoprost for the treatment of primary open-angle glaucoma: A protocol of systematic review and meta-analysis
Lu YT
Medicine 2020; 99: e20356
90753 Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
Vu JT
British Journal of Ophthalmology 2020; 104: 1040-1044
90507 The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study
Ha JY
BMC Ophthalmology 2020; 20: 277
90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Lu F
American Journal of Ophthalmology 2020; 220: 53-63
90779 Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma
Blizzard S
Ophthalmology. Glaucoma 2020; 3: 288-294
90626 Effects of Topical Prostaglandin Analog on Macular Thickness Following Cataract Surgery with Postoperative Topical Bromfenac Treatment
Kim KN
Journal of clinical medicine 2020; 9:
90461 High Correlation between Glaucoma Treatment with Topical Prostaglandin Analogs and BDNF Immunoreactivity in Human Retina
Boese EA
Current Eye Research 2020; 0: 1-7
90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Nasr M
International Journal of Pharmaceutics 2020; 583: 119402
90379 Comparison of the effectiveness and safety of travoprost and latanoprost for the management of open-angle glaucoma given as an evening dose
Wang X
Experimental and therapeutic medicine 2020; 20: 24
90697 Lower Eyelid Horizontal Tightening in Prostaglandin Associated Periorbitopathy
P L Lang M
Ophthalmic Plastic and Reconstructive Surgery 2020; 0:

Issue 21-3

Change Issue


advertisement

WGC-2021